Mad Money Lightning Round OT: Cramer Likes CELG (AMGN, CELG, EXC, NYX, BAC)

Jim Cramer said on CNBC's Mad Money Lightning Round OT that Amgen, Inc. AMGN doesn't have the growth. He recommended Celgene Corporation CELG instead, and said that it should be bought ahead of American Society of Hematology annual meeting. Amgen, Inc. (AMGN) gained 1.58% today, and Celgene Corporation (CELG) added 1.73%. Exelon Corporation EXC underperformed in the utility space, said Cramer, and added that this stock will continue to underperform if American economy continues to show signs of improvement. He explained that when economy is improving, investors usually sell utilities. Despite this, Cramer thinks that Exelon (EXC) is a solid company, and recommends it as a buy on the weakness. Exelon (EXC) added 0.18% today. Cramer thinks that NYSE Euronext NYX has a good yield, but it doesn't have a lot of growth. He likes this company, but he needs more growth. NYSE Euronext (NYX) gained 3.15% in the regular trading session, and it fell 2.93% in the after hours. Bank of America BAC is too cheap to sell, said Cramer. He added that it is not moving higher. Bank of America (BAC) gained 3.20% today, and closed at $11.29.